Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve impurity F challenges in fluvoxamine maleate production. Our one-pot process achieves 89.2% yield with no organic solvent. Contact for GMP manufacturing.
Avoid toxic azides and metal catalysts in 1,2,3-triazole synthesis. Our metal-free route offers high yields (58-83%) and simplified scale-up for API manufacturing.
Solve indole synthesis challenges with nickel-catalyzed carbonylation: 75-92% yield, one-step process, and cost-efficient production for pharma R&D and manufacturing.
Discover a scalable, high-ee synthesis method for axial chiral indolopyrrole-furan compounds with proven cytotoxic activity against PC-3 cancer cells. Reduce production costs and supply chain risks with our CDMO expertise.
Discover cost-effective, air-stable synthesis of 4-(isochromen-1-yl)isoquinoline derivatives with >89% yield. Ideal for API manufacturing.
Solve high-temperature synthesis challenges for 1,3-disubstituted allenes. Gold carbene catalysis enables room-temperature, high-yield (36-93%) production with excellent functional group tolerance. Scale up to 11g with NINGBO INNO PHARMCHEM.
Discover how copper-catalyzed quinazolinone synthesis reduces costs, eliminates hazardous reagents, and achieves 94% yields for pharmaceutical intermediates. Scale-ready solution for R&D and procurement.
Solve low-yield challenges in Balasubramide synthesis. 97% ee, 45% yield, no cytotoxicity. CDMO expertise for scalable production.
Solve ASC-J9 supply chain challenges with 95% yield, 98.6% purity, and 3h reaction time. CDMO expertise for pharma scale.
Discover the breakthrough in spirooxindole synthesis with high yield and anti-tumor activity. Optimize your drug development process with this efficient method.
Solve green chemistry challenges in CF3-introduction with metal-free electrochemical synthesis. High yields, no toxic reagents, and scalable production for pharma R&D and procurement.
Solve supply chain gaps for (2S)-2-amino-4-cyclopropylbutyric acid with novel Suzuki coupling. 99.4% purity, 91.6% yield, and no special equipment required for GMP production.
Solve supply chain risks with this novel Pd-catalyzed synthesis of quinolinone intermediates. Achieve 99% purity and 100kgs+ scale with our CDMO expertise.
Discover how chiral phosphoric acid catalysis enables high-yield, enantioselective synthesis of axial chiral aryl indoles for cancer drug development and supply chain de-risking.
Solve low-yield indolopyrrolone synthesis challenges with rhenium-catalyzed C-H activation. Achieve 95%+ yields, broad substrate tolerance, and scalable production for your drug development.
Discover a novel indolopyrrolidone synthesis method with >85% yields, eliminating expensive air-sensitive equipment. Ideal for API manufacturing and supply chain stability.
Discover a cost-effective, scalable synthesis of 2-trifluoromethyl quinazolinones using iron catalysis. Eliminate expensive reagents and improve yield for pharmaceutical intermediates.
Discover how iron-catalyzed cyclopropyl borate synthesis reduces costs and supply chain risks for pharmaceutical intermediates. Contact us for scalable production.
Solve metal residue issues in thioether synthesis with this metal-free, room-temperature method. Achieve 80-93% yields for drug intermediates with no expensive catalysts.
Solve supply chain risks with this novel 2-chlorothiophene-5-formic acid synthesis. 99.8% purity, 82% yield, and minimal waste. Ideal for rivaroxaban API production.